The tumor-bearing mice were intraperitoneally treated with anti-mouse PD-L1 mAb (anti-PD-L1; 10 mg/kg, three times a week) and cisplatin (CDDP; 1 mg/kg, once at Day1). Here, CD274 is linked to neoplasm.